OPN and BSP are particularly helpful for assessing bone metastases in lung and prostate cancers, whereas other markers such as CTGF, IL-11, and MMP-1 have demonstrated greater prognostic significance in hepatocellular carcinoma (HCC). This evidence concerns the gene IL11 and hepatocellular carcinoma.